Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9283291 | Microbes and Infection | 2005 | 7 Pages |
Abstract
Dendritic cells (DCs) induce and regulate T-cell responses, and tolerogenic DCs can promote the development of regulatory T cells with suppressive activity. The possibility of manipulating DCs using different pharmacological or biological agents, enabling them to exert tolerogenic activities, could be exploited to better control a variety of chronic inflammatory conditions, from autoimmune diseases to allograft rejection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
G. Penna, N. Giarratana, S. Amuchastegui, R. Mariani, K.C. Daniel, L. Adorini,